CellPly CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment. | ![]() Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | ![]() Egle Therapeutics Egle Therapeutics is a biotech company developing immunotherapies for oncology and autoimmune diseases. | |||
Founding Date | Founding Date 2010 | Founding Date 2013 | Founding Date 2013 | Founding Date 2015 | Founding Date 2020 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Saint-Priest, FR HQ Saint Priest, FR | Locations Bologna, IT HQ Bologna, IT | Locations Austin, US HQ | Locations South San Francisco, US HQ Louisville, US South San Francisco, US | Locations Paris, FR HQ |
Employees | Employees 20 | Employees 313% decrease | Employees 65117% increase | Employees 45 | Employees 474% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) 492.3 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income ($67.7m) (FY, 2022) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 9.8m (about 6 years ago) | Latest funding round $ 341.6k (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 46.4m (over 4 years ago) |
Total funding raised | Total funding raised $ 9.8m | Total funding raised $ 5.9m | Total funding raised N/A | Total funding raised $ 130m | Total funding raised $ 46.4m |
CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment.
View company
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View company
Harpoon Therapeutics is a preclinical stage biotechnology company.
View company
Egle Therapeutics is a biotech company developing immunotherapies for oncology and autoimmune diseases.
View company